Hildegund C J Ertl

10PUBLICATIONS
6CO-AUTHORS
Wastewater treatment processesGene and molecular therapyMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 25, 2024
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article.

Jan C Klapwijk, Alberto Del Rio Espinola, Silvana Libertini

|Oct 20, 2023
Circumventing B Cell Responses to Allow for Redosing of Adeno-Associated Virus Vectors.

Hildegund C J Ertl

|Jan 30, 2023
Mitigating Serious Adverse Events in Gene Therapy with AAV Vectors: Vector Dose and Immunosuppression.

Hildegund C J Ertl

|Mar 01, 2022
The Effect of Rapamycin and Ibrutinib on Antibody Responses to Adeno-Associated Virus Vector-Mediated Gene Transfer.

Zhiquan Xiang, Klaudia Kuranda, William Quinn

|Dec 08, 2021
Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection.

Mohadeseh Hasanpourghadi, Mikhail Novikov, Dakota Newman

|Jul 10, 2021
PPARĪ± Agonist Fenofibrate Enhances Cancer Vaccine Efficacy.

Arezki Chekaoui, Hildegund C J Ertl

Pageof 2

Frequent Collaborators

1 joint publications

Jan C Klapwijk

1 joint publications

Catherine Vickers

1 joint publications

Toni Cathomen

1 joint publications

Axel Schambach